This work aimed to perform quantitative post-treatment SPECT/CT of prostate cancer patients, who have undergone [225Ac]Ac-PSMA-I&T therapy, to study and compare the pharmacokinetics of the two SPECT-imageable daughter nuclides 221Fr and 213Bi. Here, FOLH1 is linked to prostate carcinoma.